Detailed Information

Cited 4 time in webofscience Cited 2 time in scopus
Metadata Downloads

Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional surveyopen access

Authors
Noh, Y.[Noh, Y.]Kim, J.H.[Kim, J.H.]Yoon, D.[Yoon, D.]Choe, Y.J.[Choe, Y.J.]Choe, S.-A.[Choe, S.-A.]Jung, J.[Jung, J.]Lee, S.-W.[Lee, S.-W.]Shin, J.-Y.[Shin, J.-Y.]
Issue Date
22-Jul-2022
Publisher
Korean Society of Epidemiology
Keywords
Coronavirus; Immunization; Public health; Vaccine hesitancy
Citation
Epidemiology and Health, v.44
Indexed
SCIE
SCOPUS
KCI
Journal Title
Epidemiology and Health
Volume
44
URI
https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/105503
DOI
10.4178/epih.e2022061
ISSN
1225-3596
Abstract
OBJECTIVES: This study explored predictors of coronavirus disease 2019 (COVID-19) booster hesitancy among fully vaccinated young adults and parental COVID-19 vaccine hesitancy for their children. METHODS: This cross-sectional study administered an online survey from December 2 to December 20, 2021. We enrolled participants aged 18-49 years, for whom ≥ 2 weeks had passed after their initial COVID-19 vaccination. We estimated odds ratios (ORs) with 95% confidence intervals (CIs) using multivariate logistic regression to evaluate factors associated with booster/ vaccine hesitancy. RESULTS: Among the 2,993 participants, 48.8% showed hesitancy (wait and see: 40.2%; definitely not: 8.7%). Booster hesitancy was more common among women (OR, 1.25; 95% CI, 1.05 to 1.50), younger people (OR, 1.44; 95% CI, 1.17 to 1.77), those with a lower education level (OR, 2.05; 95% CI, 1.10 to 3.82), those who received the mRNA-1273 vaccine type (OR, 2.01; 95% CI, 1.65 to 2.45), and those who experienced serious adverse events following previous COVID-19 vaccination (OR, 2.03; 95% CI, 1.47 to 2.80). The main reasons for booster hesitancy were concerns about safety (54.1%) and doubts about efficacy (29.8%). Among the 1,020 respondents with children aged < 18 years, 65.8% were hesitant to vaccinate their children against COVID-19; hesitancy was associated with younger parental age, education level, the type of vaccine the parent received, and a history of COVID-19 infection. CONCLUSIONS: Concerns about the efficacy and safety of COVID-19 vaccines were the major barrier to booster acceptance. The initial COVID-19 vaccine type (mRNA-1273), young age, gender (women), a low education level, and adverse events after the first COVID-19 vaccine were key predictors of booster hesitancy. © 2022, Korean Society of Epidemiology.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Pharmacy > Department of Pharmacy > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher SHIN, JU YOUNG photo

SHIN, JU YOUNG
Pharmacy (Pharmacy)
Read more

Altmetrics

Total Views & Downloads

BROWSE